Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 4
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Vominil 10 mg/ml V/DCP/23/0023 VetViva Richter GmbH , Austrija QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant citrate monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0023-01 1 Stikla flakons, 10 ml -
V/DCP/23/0023-02 1 Stikla flakons, 25 ml -
V/DCP/23/0023-03 1 Stikla flakons, 50 ml -
V/DCP/23/0023-04 5 Stikla flakons, 10 ml -
Alpramil mg V/DCP/22/0022 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0022-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0022-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0022-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Alpramil mg V/DCP/22/0023 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0023-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0023-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0023-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Milbetab 12,5 mg/125 mg - V/DCP/19/0045 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 09102025LI (09-Oct-2025)
Labelling text: [DOCX] 09102025M (09-Oct-2025)
Summary of product characteristics: [DOCX] 09102025ZA (09-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0045-01 12,5/125 mg 1 Blisteris, 2 tablete -
V/DCP/19/0045-02 12,5/125 mg 2 Blisteris, 2 tablete -
V/DCP/19/0045-03 12,5/125 mg 1 Blisteris, 4 tablete -
V/DCP/19/0045-04 12,5/125 mg 1 Blisteris, 8 tablete -
V/DCP/19/0045-05 12,5/125 mg 2 Blisteris, 4 tablete -
V/DCP/19/0045-06 12,5/125 mg 4 Blisteris, 2 tablete -
V/DCP/19/0045-07 12,5/125 mg 1 Blisteris, 10 tablete -
V/DCP/19/0045-08 12,5/125 mg 2 Blisteris, 10 tablete -
V/DCP/19/0045-09 12,5/125 mg 10 Blisteris, 2 tablete -
V/DCP/19/0045-10 12,5/125 mg 3 Blisteris, 10 tablete -
V/DCP/19/0045-11 12,5/125 mg 5 Blisteris, 10 tablete -
V/DCP/19/0045-12 12,5/125 mg 10 Blisteris, 10 tablete -
V/DCP/19/0045-13 12,5/125 mg 20 Blisteris, 10 tablete -
V/DCP/19/0045-14 12,5/125 mg 50 Blisteris, 10 tablete -
V/DCP/19/0045-15 12,5/125 mg 10 Atsevišķs iepakojums, 2 tablete -
V/DCP/19/0045-16 12,5/125 mg 10 Atsevišķs iepakojums, 20 tablete -
V/DCP/19/0045-17 12,5/125 mg 10 Atsevišķs iepakojums, 50 tablete -
Ketamidor 10% 100 mg/ml V/NRP/01/1290 VetViva Richter GmbH , Austrija QN01AX03 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1290-01 100 mg/ml 1 Stikla flakons, 10 ml -
Catobevit 100 mg/ml + 0,05 mg/ml - V/DCP/19/0009 KRKA, d.d., Novo mesto, Slovēnija QA12CX99 cattle; horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butaphosphan, Cyanocobalamin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Apr-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0009-01 100 mg/0,05 ml 1 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/19/0009-02 100 mg/0,05 ml 1 Stikla pudele (dzintarkrāsas), 250 ml -
Rilexine 75 mg V/NRP/07/1698 Virbac S.A., Francija QJ01DB01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1698-01 75 mg 2 Blisteris, 7 tablete [PDF]
V/NRP/07/1698-02 75 mg 30 Blisteris, 7 tablete [PDF]
Rilexine 300 mg V/NRP/07/1699 Virbac S.A., Francija QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1699-01 300 mg 2 Blisteris, 7 tablete [PDF] [PDF]
V/NRP/07/1699-02 300 mg 30 Blisteris, 7 tablete [PDF] [PDF]
Rilexine 600 mg V/NRP/07/1700 Virbac S.A., Francija QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1700-01 600 mg/tabl. 2 Blisteris, 7 tablete [PDF]
V/NRP/07/1700-02 600 mg/tabl. 30 Blisteris, 7 tablete [JPG] [JPG]
Firodyl 62.5 mg V/DCP/20/0002 Ceva Sante Animale', Francija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CEVA SANTE ANIMALE, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0002-01 62,5 mg 12 PA/Al/PVH//Al blisteris, 12 tablete -
V/DCP/20/0002-02 62,5 mg 36 PA/Al/PVH//Al blisteris, 12 tablete -
V/DCP/20/0002-03 62,5 mg 96 PA/Al/PVH//Al blisteris, 12 tablete -
Ampiclox LC - V/NRP/99/0979 Zoetis Belgium S.A., Beļģija QJ51CR50 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Ampicillin sodium, Cloxacillin sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 03-Dec-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0979-01 1 Injektors, 1 deva -
V/NRP/99/0979-02 24 Injektors, 1 deva [PDF] [PDF]
Mektix CHEWABLE 4 mg/10 mg - V/MRP/19/0031 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small cats; kittens weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 071122LI (27-Jul-2023)
Labelling text: [PDF] 21102019M (27-Jul-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0031-01 4/10 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0031-02 4/10 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0031-03 4/10 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Mektix CHEWABLE 16 mg/40 mg - V/MRP/19/0032 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 071122LI (27-Jul-2023)
Labelling text: [PDF] 21102019M (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0032-01 16/40 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0032-02 16/40 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0032-03 16/40 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Tullavis 100 mg/ml V/DCP/20/0053 Industrial Veterinaria, S.A., Spānija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0053-01 100 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/20/0053-02 100 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/20/0053-03 100 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/20/0053-04 100 mg/ml 1 Stikla flakons, 250 ml -
ZIPYRAN PLUS - V/NRP/02/1520 Laboratorios Calier, S.A., Spānija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Praziquantel, Pyrantel embonate, Febantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (14-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1520-02 1 Blisteris, 10 tablete -
V/NRP/02/1520-05 25 Blisteris, 10 tablete -
V/NRP/02/1520-06 1 Blisteris, 2 tablete -
V/NRP/02/1520-07 2 Blisteris, 10 tablete -
V/NRP/02/1520-08 10 Blisteris, 10 tablete -
Introflor Vet 300 mg/ml V/MRP/25/0069 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01BA90 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Florfenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 13-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/25/0069-01 1 Stikla flakons, 100 ml -
Duelmint 100 - V/NRP/08/1569 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1569-01 1 Plastikāta tūbiņa, 15 ml -
Domosedan Vet 10 mg/ml V/MRP/02/1451 Orion Corporation, Somija QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Orion Corporation Orion Pharma, Somija
Date of authorisation/renewal: 06-Jun-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Summary of product characteristics: [DOCX] 29062020ZA (10-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/02/1451-01 10 mg/ml 1 Stikla flakons, 5 ml -
V/MRP/02/1451-02 10 mg/ml 1 Stikla flakons, 20 ml -
V/MRP/02/1451-03 10 mg/ml 6 Stikla flakons, 5 ml -
V/MRP/02/1451-04 10 mg/ml 10 Stikla flakons, 5 ml -
V/MRP/02/1451-05 10 mg/ml 5 Stikla flakons, 20 ml -
V/MRP/02/1451-06 10 mg/ml 10 Stikla flakons, 20 ml -
Alfasalix 1000 mg/g V/DCP/25/0070 Alfasan Nederland BV, Nīderlande QN02BA04 cattle (calf); pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water
International name (active substance): Sodium salicylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0070-01 1 Maiss, 100 g -
V/DCP/25/0070-02 1 Maiss, 1 kg -
V/DCP/25/0070-03 1 Maiss, 5 kg -
Ototop - V/DCP/20/0030 Industrial Veterinaria, S.A., Spānija QS02CA01 guinea pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: ear drops and cutaneous suspension
International name (active substance): Miconazole nitrate, Prednisolone acetate, Polymyxin B sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0030-01 1 ZBPE pudelīte, 15 ml -
V/DCP/20/0030-02 1 ZBPE pudelīte, 30 ml -
V/DCP/20/0030-03 1 ZBPE pudelīte, 100 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy